Cargando…
Identification of γ-Synuclein as a Stage-Specific Marker in Bladder Cancer by Immunohistochemistry
BACKGROUND: Previous studies have shown that the expression level of γ-synuclein (SNCG) is associated with progression of many different malignant tumors. In this study, we discuss and assess the prognostic ability of SNCG in bladder cancer. MATERIAL/METHODS: Medical records (2005–2013) were retrosp...
Autores principales: | Zhao, Jiyu, Xing, Nianzeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266204/ https://www.ncbi.nlm.nih.gov/pubmed/25479371 http://dx.doi.org/10.12659/MSM.892927 |
Ejemplares similares
-
Urine gamma-synuclein as a biomarker for the diagnosis of bladder cancer
por: Liu, Caiyun, et al.
Publicado: (2016) -
Postoperative spindle cell nodule of the bladder: A case report and review of the literature
por: ZHAO, JIYU, et al.
Publicado: (2014) -
γ-Synuclein as a marker of retinal ganglion cells
por: Surgucheva, Irina, et al.
Publicado: (2008) -
The prognostic value of the stem-like group in colorectal cancer using a panel of immunohistochemistry markers
por: Ong, Chee Wee, et al.
Publicado: (2015) -
Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
por: Raghavendran, M., et al.
Publicado: (2016)